Online Only Articles

The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells

Department of Internal Medicine V, University of Heidelberg, Germany
Department of Internal Medicine V, University of Heidelberg, Germany;Department of Molecular & Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
Centre for Myeloma Research, Division of Molecular Pathology, Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK
Department of Internal Medicine V, University of Heidelberg, Germany
INSERM, Unité 1040, Institut de Recherche en Biothérapie, Centre Hospitalier Universitaire de Montpellier, Hôpital Saint Eloi, Avenue Augustin Fliche, 34295 Montpellier, France
German Cancer Research Center, Heidelberg, Germany;Center for Primary Health Care Research, Lund University, Malmo, Sweden
German Cancer Research Center, Heidelberg, Germany
Department of Internal Medicine V, University of Heidelberg, Germany
Molecular and Population Genetics, Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK
Haematological Malignancy Diagnostic Service Laboratory, St James University Hospital, Leeds, UK
Haematological Malignancy Diagnostic Service Laboratory, St James University Hospital, Leeds, UK
Centre for Myeloma Research, Division of Molecular Pathology, Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK
Centre for Myeloma Research, Division of Molecular Pathology, Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK
Department of Haematology, University College London Hospital, UK
Centre for Myeloma Research, Division of Molecular Pathology, Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK
Institute of Human Genetics, University of Bonn, Germany;Division of Medical Genetics, Department of Biomedicine, University of Basel, Switzerland
Institute of Human Genetics, University of Bonn, Germany;Department of Genomics, Life & Brain Center, University of Bonn, Germany
Centre for Myeloma Research, Division of Molecular Pathology, Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK
INSERM, Unité 1040, Institut de Recherche en Biothérapie, Centre Hospitalier Universitaire de Montpellier, Hôpital Saint Eloi, Avenue Augustin Fliche, 34295 Montpellier, France
Department of Internal Medicine V, University of Heidelberg, Germany;National Centre for Tumor Diseases, Heidelberg, Germany
Centre for Myeloma Research, Division of Molecular Pathology, Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK
Molecular and Population Genetics, Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK
Department of Internal Medicine V, University of Heidelberg, Germany;National Centre for Tumor Diseases, Heidelberg, Germany
German Cancer Research Center, Heidelberg, Germany;Center for Primary Health Care Research, Lund University, Malmo, Sweden
Vol. 100 No. 3 (2015): March, 2015 https://doi.org/10.3324/haematol.2014.118786